Russell Investments Group, Ltd.
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 1692234
Seattle, WA
Position in VRDN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$4,587,815
-$1,433,248 QoQ
Shares Held
234,551
+21.2% QoQ
Ownership
0.228%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Russell Investments Group, Ltd. holds $1,223,802,944 across 266 Biotechnology names. VRDN ranks #48 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
228,086 | $176,228,356 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
367,691 | $164,188,731 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,397,958 | $67,060,041 | |
| 4 | INCY |
Incyte Corp
|
638,242 | $60,071,331 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
147,533 | $48,814,236 | |
| 6 | MRNA |
Moderna, Inc.
|
710,640 | $36,100,509 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
606,224 | $34,245,589 | |
| 8 | INSM |
INSMED Inc
|
169,162 | $27,661,365 |
All Filings in VRDN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,587,815 | 234,551 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $6,021,063 | 193,479 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,913,233 | 134,997 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,228,629 | 87,885 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,672,515 | 198,258 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $7,276,853 | 379,596 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $10,063,097 | 442,334 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,548,698 | 349,631 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $5,631,319 | 321,606 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $7,176,159 | 329,484 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $4,588,821 | 299,141 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,462,858 | 103,525 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,155,657 | 84,735 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $2,486,558 | 85,127 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $918,826 | 44,799 | Shares | Sole | 2022-11-04 | |
| No filing history on record for this holder in this stock. | ||||||